Alternatives and formula-comparison guide

    Sensivion Alternatives: Neuvelys, Simpler Supplements and Evidence-Based Options

    Neuvelys is the closest branded Sensivion alternative identified because the supplied labels appear to list the same principal ingredients and amounts. If that match remains current, switching between them changes the branding, marketing and possibly the seller or checkout — not the core labelled formula.

    That makes Neuvelys a close commercial alternative, but not necessarily a meaningfully different formula. JeffsReviews has not confirmed that the two products share a manufacturer, raw materials or production process.

    A simpler single-ingredient supplement reduces formula complexity, but it is not automatically more effective and is not an established tinnitus treatment.

    For visitors seeking an evidence-aligned alternative to buying another supplement, audiological assessment, hearing support when hearing loss is present and tinnitus-related CBT for ongoing distress may be more relevant routes.

    Jeff has not personally used or directly compared Sensivion and Neuvelys.

    By Jeff, Editor-in-ChiefPublished 28 July 2026Sensivion and Neuvelys comparison checked on 28 July 2026

    This is a comparative editorial analysis. It is not personal medical advice, a diagnosis, a treatment plan, a claim that one route is suitable for every person, or proof that any supplement treats tinnitus.

    Sensivion food supplement bottle used as the baseline product in this alternatives comparison
    Sensivion (baseline)
    Neuvelys food supplement bottle presented as the closest branded label-level comparison to Sensivion
    Neuvelys (closest branded comparison)

    Sensivion alternatives at a glance

    Closest branded comparison:
    Neuvelys
    Current classification:
    Potentially the same principal labelled formula, subject to a current label recheck
    Meaningfully different formula?:
    Not established from the supplied labels
    Simpler route:
    A single-ingredient product with a clearly disclosed amount and form
    Does simpler mean proven for tinnitus?:
    No
    Strongest guideline alignment:
    Assessment and management based on hearing status and impact
    Hearing support:
    Relevant only when hearing loss is present and appropriately assessed
    Tinnitus-related CBT:
    A management option for distress and day-to-day impact
    Sound support:
    Possible option; evidence and guideline recommendations are less certain
    Lowest product commitment:
    Do not purchase another supplement
    Finished-product proof for Sensivion:
    Not established
    Finished-product proof for Neuvelys:
    Not established from the evidence located
    Tested by Jeff:
    No

    Main conclusion: the most useful alternative depends on what the visitor wants to change — branding, formula complexity, evidence standard or the decision to buy a supplement at all.

    JeffsReviews may earn a commission if you purchase Sensivion through links on this page, at no additional cost to you. Jeff has not used or directly compared Sensivion and Neuvelys. The page also discusses non-commercial options and does not receive a commission when a reader chooses not to purchase a supplement.

    What makes an alternative meaningfully different?

    The comparison considers principal formula, ingredient amounts and forms, excipients, serving instructions, bottle size, current official positioning, finished-product evidence, formula complexity, safety and interaction complexity, seller and checkout, total purchase commitment, whether a product purchase is required, guideline relevance and the main buyer objective.

    A different bottle design or brand name does not automatically create a meaningfully different formula. Non-supplement routes are included because some visitors are not looking for another bottle — they are looking for a better-supported way to assess or manage the problem.

    Different branding ≠ different formula
    Simpler formula ≠ proven tinnitus treatment

    What is being replaced when someone looks for a Sensivion alternative?

    According to the supplied Sensivion label: 30 capsules per bottle, one capsule daily for adults, magnesium 80 mg (21% NRV), alpha-lipoic acid 100 mg, butcher's-broom root extract 50 mg, L-carnitine 10 mg, turmeric rhizome extract 10 mg standardised to 95% curcuminoids, and coenzyme Q10 5 mg as ubiquinone.

    At the time of the current source check, the official Sensivion page used restrained wording around magnesium, normal functioning of the nervous system, simple daily use and food-supplement status.

    The Sensivion alternative question is therefore not only "Which product has similar ingredients?" It is also "Does the buyer want the same formula, fewer ingredients or a completely different approach?"

    See the complete Sensivion formula and label analysis

    Neuvelys is the closest comparison — but may not change the formula

    Comparing the supplied Sensivion and Neuvelys labels, the principal ingredients and amounts appear to overlap. Where the current labels match, the honest editorial description is: the supplied Sensivion and Neuvelys labels list the same principal ingredients and amounts.

    That does not prove that the finished products are chemically identical, made by the same manufacturer or produced under identical conditions. It does not establish shared raw materials, identical excipients, identical bioavailability, identical sellers or identical return conditions.

    JeffsReviews therefore uses "label-equivalent principal formula" only when the current line-by-line comparison supports it, and avoids terms such as "exact same product", "identical product", "rebrand", "white-label duplicate", "copy" or "clone" unless reliable corporate or manufacturing evidence establishes them.

    Sensivion and Neuvelys label comparison

    A current label recheck is required before publication. Neuvelys values are represented as "use verified current label" so that any change on the Neuvelys side triggers an explicit re-check rather than a silent assumption of overlap.

    Capsule count

    Sensivion: 30 capsules

    Neuvelys: Use verified current label

    Current recheck required

    Determines how many days one bottle covers.

    Suggested use

    Sensivion: One capsule daily for adults

    Neuvelys: Use verified current label

    Current recheck required

    Doubling the serving doubles ingredient exposure and cost.

    Magnesium

    Sensivion: 80 mg, 21% NRV

    Neuvelys: Use verified current label

    Current recheck required

    Sets total daily magnesium intake and NRV contribution.

    Alpha-lipoic acid

    Sensivion: 100 mg (form not specified)

    Neuvelys: Use verified current label

    Current recheck required

    Form and isomer influence stability and comparability with research.

    Butcher's broom

    Sensivion: 50 mg Ruscus aculeatus root extract

    Neuvelys: Use verified current label

    Current recheck required

    Preparation and extract ratio determine what the amount represents.

    L-carnitine

    Sensivion: 10 mg

    Neuvelys: Use verified current label

    Current recheck required

    Form (L-carnitine vs acetyl-L-carnitine) affects comparability with tinnitus case-study evidence.

    Turmeric

    Sensivion: 10 mg rhizome extract, 95% curcuminoids

    Neuvelys: Use verified current label

    Current recheck required

    Standardisation and absorption format materially change intake.

    Coenzyme Q10

    Sensivion: 5 mg as ubiquinone

    Neuvelys: Use verified current label

    Current recheck required

    Form (ubiquinone vs ubiquinol) and amount define comparability with pilot research.

    Capsule shell

    Sensivion: Hypromellose (vegetable)

    Neuvelys: Use verified current label

    Current recheck required

    Affects suitability for people avoiding gelatine.

    Excipients

    Sensivion: Microcrystalline cellulose, magnesium salts of edible fatty acids, silicon dioxide

    Neuvelys: Use verified current label

    Current recheck required

    Complete excipient overlap is required to describe formulas as label-equivalent.

    Warnings

    Sensivion: Standard adult food-supplement warnings; not for under-18s, pregnant or nursing mothers

    Neuvelys: Use verified current label

    Current recheck required

    Warning parity matters when comparing safety.

    Distributor

    Sensivion: Digistore24 MSLW Limited, Dublin, Ireland

    Neuvelys: Use verified current label

    Current recheck required

    Distributor identity is separate from manufacturing identity.

    Net weight

    Sensivion: 17 g

    Neuvelys: Use verified current label

    Current recheck required

    Sanity check for capsule count and fill.

    The current Neuvelys website must be checked against the physical label

    During one current page check, the Neuvelys landing page displayed stronger tinnitus-relief marketing, references to ringing, calm, focus and hearing, and a "two capsules a day" statement. The previously supplied Neuvelys label displayed one capsule daily.

    This is treated as a possible website-versus-label discrepancy that requires a fresh live check. Buyers should not silently pick one wording over the other, and daily ingredient intake should not be recalculated until the serving discrepancy is resolved.

    The current Neuvelys website and supplied label do not present the same daily-use wording. Buyers should follow the physical label supplied with the product and seek clarification from the responsible seller when online directions conflict.

    This page does not recommend taking two capsules, taking one capsule, doubling the labelled amount, or following a marketing page over a physical label. It flags the conflict and stops there.

    The brands may use different marketing even when labels overlap

    Sensivion

    • Magnesium
    • Normal nervous-system function
    • Daily routine
    • Clear product information

    Neuvelys

    • Tinnitus relief
    • Ringing
    • Calm
    • Focus
    • Hearing support
    • Ear health

    Different marketing language does not establish a different formula or a stronger clinical result. Stronger promotional wording does not become clinical evidence, and merchant claims are not editorial fact.

    Does either formula have stronger finished-product evidence?

    Sensivion

    Clearly matching finished-product human trial: not located in the completed searches.

    Neuvelys

    Clearly matching finished-product human trial: not located from the evidence reviewed.

    Ingredient studies are not finished-product trials, a matching label does not transfer a clinical trial, stronger marketing does not create stronger evidence, merchant testimonials are not clinical outcomes, a commercial guarantee is not efficacy evidence, a large package is not evidence, and an authorised magnesium claim is not proof of tinnitus improvement.

    Neither product has a demonstrated finished-product advantage based on the evidence located.

    Complete Sensivion effectiveness and clinical-evidence analysis · Complete Neuvelys effectiveness analysis

    Compare total commitment — not only the per-bottle headline

    Per-bottle headlines can look similar while total package commitment, shipping wording, VAT wording, seller, checkout provider, payment frequency and return conditions differ. The reliable comparison is total payment on the same checkout, on the same day, in the same currency.

    Current total-cost comparison unavailable in this page's fixed content — check each dedicated buying guide for the most recent verified figures.

    Current Sensivion package totals and checkout terms · Current Neuvelys package totals and checkout terms

    A simpler formula can be easier to evaluate — but is not automatically more effective

    Potential advantages

    • Fewer active ingredients
    • Easier label interpretation
    • Easier form comparison
    • Easier total-intake calculation
    • Fewer simultaneous ingredient uncertainties
    • Easier attribution if an unwanted effect occurs
    • Potentially lower purchase commitment

    Important limitations

    • Simpler does not mean clinically proven
    • Simpler does not mean safer for every person
    • A single ingredient can still interact with medicines
    • The relevant dose and form may be uncertain
    • A nutrient may be unnecessary
    • Ingredient studies may not apply to an individual
    • Research doses should not be reproduced without professional advice

    This page does not recommend a specific retail single-ingredient product and does not add unauthorised retailer links.

    Magnesium alone removes five ingredients — but not the evidence gap

    Sensivion contains 80 mg of magnesium per capsule. A magnesium-only product may offer one active ingredient, a clearer magnesium form, a clearer elemental amount and easier comparison with total dietary and supplemental intake.

    Magnesium is not an established tinnitus treatment. Sensivion's authorised claim concerns normal nervous-system function, which does not establish symptom improvement. Existing tinnitus research used different amounts in weak study designs, different magnesium forms are not automatically interchangeable, more magnesium is not automatically better and additional intake may be inappropriate for some people.

    A magnesium-only product is a formula-simplicity alternative, not a proven tinnitus alternative.

    Alpha-lipoic acid alone offers clearer dosing — but no direct Sensivion replacement evidence

    Sensivion contains 100 mg alpha-lipoic acid with an unspecified form. A standalone product may make it easier to evaluate exact amount, isomer or form, excipients and serving frequency.

    Relevant studies used materially different amounts, study designs were limited, standalone research did not test Sensivion, a higher amount is not automatically appropriate, alpha-lipoic acid can have safety and interaction considerations, and it is not an established tinnitus treatment.

    This is a transparency and simplicity alternative — not a demonstrated outcome replacement.

    CoQ10 alone is simpler, but the tinnitus pilot does not establish a benefit

    Sensivion contains 5 mg CoQ10 as ubiquinone. A standalone product may disclose the exact CoQ10 amount, whether it is ubiquinone or ubiquinol, any carrier or delivery system and the serving.

    A small tinnitus pilot used approximately 300 mg daily, found no overall tinnitus-score effect, was nonrandomised, and its subgroup observation was exploratory. It did not test Sensivion and does not establish that standalone CoQ10 treats tinnitus.

    A CoQ10-only product changes formula complexity, but current evidence does not make it a proven tinnitus solution.

    Audiological assessment moves from product selection to diagnosis

    An audiological assessment is an evidence-aligned starting point when hearing status is unclear or symptoms are new or concerning. It does not promise a cure or a specific cause, and it is not a supplement purchase. NICE NG155 (2020) and the AAO-HNS 2014 clinical practice guideline both frame appropriate assessment as the basis for the management route.

    Hearing support belongs to a specific group — not everyone with tinnitus

    Where hearing loss is present and appropriately assessed, hearing support is a guideline-supported route. It is not an appropriate route for tinnitus without confirmed hearing loss. This page therefore does not recommend hearing devices to someone without hearing loss.

    Tinnitus-related CBT addresses distress and impact

    Tinnitus-related cognitive behavioural therapy is a guideline-supported management option for appropriate adults. It targets the distress and day-to-day impact of tinnitus rather than promising removal of the sound or a cure.

    Sound and environmental support: possible, not guaranteed

    Sound and environmental strategies are sometimes helpful, but guideline recommendations and evidence quality differ between AAO-HNS and NICE. This page presents sound support as a possibly useful low-commitment option, not a guaranteed route.

    Choosing no new supplement is a legitimate alternative

    When the evidence, formula complexity, checkout or package commitment does not meet the buyer's threshold, doing nothing about supplement purchasing is a valid alternative. It should not be used to delay appropriate assessment of new or concerning symptoms.

    The best alternative depends on what you want to change

    Closest branded comparison

    Neuvelys

    Only after confirming the current label; may be a branding alternative rather than a new formula.

    Fewer ingredients

    A clearly labelled single-ingredient category

    Simpler does not mean proven or suitable.

    Strongest evidence standard

    Assessment and guideline-aligned management

    The appropriate route depends on hearing status and tinnitus impact.

    Hearing loss is present

    Professional hearing-device evaluation

    Not for tinnitus without hearing loss.

    Distress is the main problem

    Tinnitus-related CBT or appropriately delivered psychological support

    Aims to reduce impact rather than promise elimination of the sound.

    Lowest purchase commitment

    No new supplement or low-cost environmental sound support

    Must not delay appropriate assessment.

    Wants the original six-ingredient formula

    Sensivion remains the baseline option

    Only with realistic expectations and after reviewing the label, warnings, seller and total price.

    Full comparison matrix

    Sensivion

    What changes: Baseline six-ingredient food supplement

    Direct evidence: No clearly matching finished-product trial located

    Purchase: Bottle purchase

    Main advantage: Discloses a complete ingredient list at declared amounts

    Main limitation: No finished-product effectiveness proof

    Suits: Buyer wants the original disclosed formula

    Neuvelys

    What changes: Different brand; principal labelled formula may overlap

    Direct evidence: No clearly matching finished-product trial located from the evidence reviewed

    Purchase: Bottle purchase

    Main advantage: Closest label-level comparison to Sensivion

    Main limitation: May change branding without changing the core formula; current website-versus-label wording may differ

    Suits: Buyer wants the closest branded comparison

    Simpler single-ingredient supplement

    What changes: One active ingredient at a clearly disclosed amount

    Direct evidence: Ingredient studies exist; not a Sensivion replacement trial

    Purchase: Bottle purchase

    Main advantage: Easier to evaluate amount, form and interactions

    Main limitation: Simpler does not mean proven or automatically suitable

    Suits: Buyer prioritises formula simplicity

    Audiological assessment

    What changes: Moves from product selection to hearing-status assessment

    Direct evidence: Guideline-aligned assessment route

    Purchase: Not a supplement purchase

    Main advantage: Can inform relevant management

    Main limitation: Does not promise a cure or specific cause

    Suits: Buyer prioritises assessment

    Hearing support (with hearing loss)

    What changes: Addresses hearing function where loss is present

    Direct evidence: Guideline-supported in the appropriate group

    Purchase: May involve a device or service

    Main advantage: Relevant to assessed hearing loss

    Main limitation: Not appropriate for tinnitus without hearing loss

    Suits: Buyer has confirmed hearing loss

    Tinnitus-related CBT

    What changes: Targets distress and daily impact

    Direct evidence: Guideline-supported for appropriate adults

    Purchase: May involve a service

    Main advantage: Addresses the impact of tinnitus

    Main limitation: Does not promise removal of the sound

    Suits: Buyer's main difficulty is ongoing distress

    Sound and environmental support

    What changes: Changes the sound environment

    Direct evidence: Mixed and approach-dependent

    Purchase: Not necessarily

    Main advantage: Can be low commitment

    Main limitation: Guideline uncertainty and variable response

    Suits: Buyer wants a practical environmental strategy

    No new supplement

    What changes: Avoids another product purchase

    Direct evidence: Not an intervention claim

    Purchase: No

    Main advantage: No additional formula or package commitment

    Main limitation: Does not replace assessment when needed

    Suits: Evidence threshold or purchase confidence not met

    Changing products does not automatically remove safety concerns

    • Neuvelys may retain the same ingredient-level concerns when its label matches Sensivion.
    • Switching brands does not remove an ingredient interaction.
    • A single ingredient may still have meaningful precautions.
    • Combining Sensivion with another supplement can duplicate ingredients.
    • More capsules can increase exposure.
    • A marketing-page serving should not override the product label.
    • Visitors should not combine products to reproduce research amounts.
    • Product-specific warnings must be checked.

    Complete Sensivion side-effects and interaction guide · Complete Neuvelys safety guide

    Questions to answer before choosing an alternative

    • Do I want a different brand or a different formula?
    • Does the current label actually differ?
    • Are the principal ingredient amounts different?
    • Does the website serving match the physical label?
    • Is the ingredient form disclosed?
    • Am I looking for clinical evidence or only formula similarity?
    • Is the product supported by a finished-product trial?
    • Is the total package payment clear?
    • Is the seller identified?
    • Is the payment one-time or recurring?
    • Are shipping and return conditions clear?
    • Does the alternative duplicate ingredients I am already taking?
    • Have the warnings and interactions been reviewed?
    • Is hearing loss present?
    • Is distress the main issue?
    • Would an assessment be more useful than another supplement?
    • Am I relying on a testimonial rather than evidence?
    • Would choosing no new product better match my evidence threshold?

    A useful alternative should change the factor that matters — not merely the brand name.

    Sensivion alternatives: strengths and limitations

    Strengths of this comparison

    • Uses genuine supplied product labels
    • Compares principal ingredient amounts
    • Separates branding from formula differences
    • Includes non-commercial alternatives
    • Does not assume a supplement is the correct answer
    • Distinguishes clinical evidence from marketing
    • Accounts for formula complexity
    • Includes purchase commitment
    • Includes safety and interaction considerations
    • Uses recognised tinnitus guidance
    • Provides objective-based choices
    • Discloses Jeff's lack of personal testing

    Important limitations

    • Labels and websites can change
    • The Neuvelys website and supplied label may conflict
    • Matching labels do not prove identical manufacturing
    • Seller and checkout entities may differ
    • Current prices are volatile
    • No personal-use comparison was performed
    • No laboratory testing was performed
    • No alternative is universally suitable
    • No single ingredient is an established tinnitus treatment
    • Hearing support depends on hearing loss
    • CBT addresses distress rather than proving sound elimination
    • Sound-support evidence is uncertain
    • Public guidance cannot determine an individual's needs

    Sensivion alternatives verdict: Neuvelys is the closest label match, but the most meaningful alternative may not be another supplement

    Neuvelys is the closest branded Sensivion alternative located. The supplied labels appear to list the same principal ingredients and amounts, so it may change the branding, marketing, seller or checkout without providing a meaningfully different core formula.

    That label overlap does not prove the finished products are identical, share a manufacturer or produce the same effects. The current Neuvelys website must also be reconciled with its supplied label because the online daily-use wording may differ.

    A single-ingredient supplement can reduce formula complexity and make the amount and form easier to evaluate. It does not, however, become an established tinnitus treatment simply because it contains fewer ingredients.

    For someone whose priority is the strongest evidence-aligned route, audiological assessment, hearing support where hearing loss is present, and tinnitus-related CBT where distress continues are more meaningfully different from Sensivion than switching between two similar supplement labels.

    Sound or environmental support may be a low-commitment option, although guidelines differ and the evidence does not support a guaranteed result.

    Choosing not to purchase another supplement is also reasonable when the evidence, formula complexity, checkout or package commitment does not meet the buyer's threshold. That decision should not be used to delay appropriate assessment of new or concerning symptoms.

    No single alternative is best for everyone. Neuvelys is the closest commercial comparison; a single-ingredient product is the simpler formula route; assessment and appropriately selected management are the stronger evidence-oriented route.

    Sensivion remains relevant only for buyers who specifically want its six-ingredient formula, understand the evidence limitations and verify the current label, warnings, seller and complete package cost.

    Jeff has not used or directly compared Sensivion and Neuvelys.

    JeffsReviews may earn a commission if you purchase Sensivion through this link, at no additional cost to you. Jeff has not used or directly compared Sensivion and Neuvelys.

    If Sensivion still best matches your preferred formula, use the current merchant page to verify the label, serving, seller, complete package total and guarantee terms before deciding.

    Check the current Sensivion label and offer

    Our Sensivion research

    Frequently asked questions

    Sources

    Sensivion label and official information

    1. [1] Sensivion. "Genuine supplied Sensivion English label." Sensivion, 2026. Sensivion formula, amounts, serving, excipients, warnings and distributor. View source
    2. [2] Sensivion. "Current official Sensivion English page." Sensivion, 2026. Current public positioning and daily-use wording; not used as independent effectiveness evidence. View source

    Neuvelys label and official information

    1. [3] Neuvelys. "Genuine supplied Neuvelys English label." Neuvelys, 2026. Neuvelys formula, amounts, serving, excipients, warnings and distributor. View source
    2. [4] Neuvelys. "Current official Neuvelys English page." Neuvelys, 2026. Current public positioning, daily-use wording and merchant outcome claims; not used as independent effectiveness evidence. View source

    Current systematic-review evidence

    1. [5] Menon R, Ziner J, Tolordava A, et al.. "Effectiveness of Over-The-Counter Treatments for Tinnitus Symptom Relief: A Systematic Review." Laryngoscope Investigative Otolaryngology, 2026. OTC tinnitus evidence heterogeneity and absence of firm conclusions. View source

    NICE tinnitus guidance

    1. [6] National Institute for Health and Care Excellence. "Tinnitus: assessment and management (NG155)." NICE, 11 March 2020. Audiological assessment, hearing-device recommendations where hearing loss is present, stepped psychological support, CBT and sound-therapy uncertainty. View source

    AAO-HNS tinnitus guidance

    1. [7] American Academy of Otolaryngology–Head and Neck Surgery Foundation. "Clinical Practice Guideline: Tinnitus." AAO-HNSF, 2014. Hearing-aid evaluation with hearing loss, CBT recommendation, sound therapy as an option, and dietary supplements not recommended for persistent, bothersome tinnitus. View source

    Regulatory health-claim context

    1. [8] European Commission. "Nutrition and Health Claims." European Commission. Authorised nutrient-function wording context. View source
    2. [9] European Commission. "EU Register of Health Claims." European Commission. Authorised magnesium wording; difference between nutrient-function claims and finished-product proof. View source